Eyeing COVID-19 shortages, FDA unleashes compounded drugs to treat hospital patients

After a series of high-profile failures in the early 2010s, the compounding pharmacy industry took its share of body blows from an FDA looking to impose its will.

Now, after years of lockdown, the FDA is turning to its old nemesis to help ease the burden COVID-19 has placed on hard-hit hospitals.